lung cancer
Conditions
Interventions
Experimental Group:Before recruiting participants, potential subjects will undergo a screening visit or a pre-adaptation period, which includes 1 or 2 sessions of virtual reality-cognitive response th
Control group:The control group will receive routine care and standard oncological treatment but will not participate in any structured cognitive training intervention.
To maintain engagement and as
Sponsors
Nanjing Brain Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: a. aged 18–75 years with a pathological diagnosis of stage I–IV non-small cell lung cancer; b. an estimated life expectancy of at least 6 months; c. being conscious and possessing the basic ability to use a tablet or smartphone independently or with minimal assistance; d. voluntary participation with signed informed consent.
Exclusion criteria
Exclusion criteria: a. Brain metastases or leptomeningeal metastases confirmed by MRI/CT; b. History of diagnosed psychiatric disorders (e.g., schizophrenia, major depressive disorder with psychotic features) or neurological diseases (e.g., dementia, Parkinson's disease, epilepsy); c. Severe visual or hearing impairment, uncontrolled pain, or poor physical condition (ECOG score > 2) that would prevent completion of VR training; d. History of motion sickness in specific situations; e. Concurrent participation in other clinical trials involving cognitive interventions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective Cognitive Function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective Cognitive Function;Quality of Life;Secondary outcomes of simulation sickness;Treatment satisfaction;User-Friendliness and Engagement; | — |
Countries
China
Contacts
Public ContactYe Lei
Nanjing Brain Hospital
Outcome results
None listed